Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial
scientific article published on 15 April 2019
Author/s
author: Dominic Paquin-Proulx, Barney S. Graham, John R. Mascola, Nicole Doria-Rose, Adrian B. McDermott, Julie Ledgerwood, Nelson Michael, Merlin L Robb, Randall L Tressler, Kayvon Modjarrad, Trevor A Crowell, Donn Colby, Suteeraporn Pinyakorn, Carlo Sacdalan, Amélie Pagliuzza, Jintana Intasan, Khunthalee Benjapornpong, Sodsai Tovanabutra, Morgane Rolland, Diane L Bolton, Lydie Trautmann, Shelly J. Krebs, Nicolas Chomont, Nittaya Phanuphak, Jintanat Ananworanich, Michael A Eller, Eugène D M B Kroon, Brandie Fullmer, Rasmi Thomas, Alexandra Schuetz
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.